What are the Historical Developments and Current Growth Metrics of the Artificial Lung Market?
The artificial lung market has seen considerable growth due to a variety of factors.
• The artificial lung market has expanded significantly in recent years. It is projected to increase from $2.31 billion in 2024 to $2.59 billion in 2025, at a compound annual growth rate (CAGR) of 12.2%.
This growth can be attributed to growing awareness among healthcare professionals, greater market penetration, increased use in home care settings, a rise in medical tourism, and advancements in healthcare infrastructure.
What Does Future Hold for The Artificial Lung Market By 2029?
The artificial lung market is expected to maintain its strong growth trajectory in upcoming years.
• The artificial lung market is forecasted to experience significant growth, reaching $4.06 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%.
This expansion is driven by an increase in respiratory diseases, advancements in healthcare, the growing popularity of minimally invasive procedures, improved patient quality of life, and a rise in chronic obstructive pulmonary diseases. Notable trends include the integration of wireless and AI technologies, progress in genomics and medical tech, and the development of more compact and portable artificial lungs.
What Are The Primary Growth Drivers In The Artificial Lung Market?
The artificial lung market is projected to grow due to the increasing prevalence of respiratory diseases, a trend driven by factors like rising air pollution, lifestyle changes, and climate change. Artificial lungs support individuals with respiratory diseases by assisting with oxygenation and carbon dioxide removal. For example, in 2024, the Australian Institute of Health and Welfare estimated that 8.5 million Australians, or 34% of the population, suffer from chronic respiratory conditions, with 2.8 million people living with asthma and 638,000 with chronic obstructive pulmonary disease (COPD). This growing health burden will continue to drive demand for artificial lung devices.
What Is The Segmentation Of The Global Artificial Lung Market?
The artificial lung market covered in this report is segmented –
1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
3) By End-Users: Hospital, Emergency Center, Other End-users
Subsegments:
1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung
Pre-Book The Artificial Lung Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Artificial Lung Market?
Companies in the artificial lung market are advancing their solutions by integrating remote monitoring and control features to improve patient safety and care. This technology enables healthcare professionals to remotely monitor patients' vital signs and adjust ventilator settings, reducing the risk of infection. For example, in August 2022, Teltonika Telemedic, a US-based electronics manufacturer, made significant strides with its artificial lung ventilator, TELTOMED. The device features secure remote data transmission and control, offering enhanced security and reliability for patient data communication, a vital feature for modern medical equipment.
Who Are the Key Players In The Artificial Lung Market?
Major companies operating in the artificial lung market are:
• Terumo Corporation
• Getinge AB
• Abiomed Inc.
• MicroPort Scientific Corp.
• Charles Stark Draper Laboratory Inc.
• TransMedics Group Inc.
• Braile Biomédica Ltd.
• Xenios AG
• MC3 Cardiopulmonary Inc.
• Lung Biotechnology PBC
• Breethe Inc.
• Levitronix LLC
• Medos Medizintechnik AG
• ALung Technologies Inc.
• McGowan Institute for Regenerative Medicine
• Hemovent GmbH
• Novalung GmbH
• Haemair Ltd.
• MedArray Inc.
• Vivonics Inc.
• Extracorporeal Life Support (ECLS) Lab
What Are The Regional Insights Into The Artificial Lung Market?
North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
